BioSpace News Archive

Innate Pharma SA reported its consolidated financial results for the six months ended June 30, 2023.

CancerVAX, Inc. announced that in a recent podcast its CEO, Ryan Davies, spoke about the Company’s growing pipeline of cancer treatments under development at UCLA.

PathMaker Neurosystems Inc. announced the initiation of a first-in-human clinical trial evaluating its MyoRegulator® device for the treatment of amyotrophic lateral sclerosis.

Fujitsu announced the launch of an innovative solution to its Uvance Healthy Living portfolio to transform surgical capacity utilization with a new approach in the market by targeting the root cause of surgical block time inefficiencies.

Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced that the Company will present at Goldman Sachs Global Sustainability Forum in New York on September 27, 2023, at 12:15 p.m. Eastern time.

BioCT is pleased to announce the appointment of Carter Winstanley, Principal of Winstanley Enterprises, to its Board of Directors.

Curasight A/S (“Curasight” or the “Company” - TICKER: CURAS) announces today that the previously announced results from the investigator-initiated phase II study using uPAR-PET (uTRACE®) in primary brain cancer have been presented in an oral presentation at the World Molecular Imaging Congress (WMIC) 2023 in Prague.

Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today announced data supporting the breakthrough potential of its Gene Expression Modulation System (GEMS) platform for epigenetic engineering.

Ryvu Therapeutics (WSE: RVU) today announced that Ryvu’s licensee, the Menarini Group, will expand development of MEN1703 (SEL24) by initiating a new Phase II study in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) in addition to continued translational work in other hematologic indications.

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, presented 21 new scientific and clinical studies on the company’s Equinoxe® shoulder at the 2023 International Congress on Shoulder and Elbow Surgery (ICSES) annual meeting Sept. 5-8 in Rome.